Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 25
1973 65
1974 105
1975 65
1976 76
1977 101
1978 63
1979 74
1980 82
1981 53
1982 78
1983 92
1984 71
1985 54
1986 44
1987 39
1988 43
1989 39
1990 43
1991 33
1992 22
1993 15
1994 8
1995 11
1996 11
1997 21
1998 21
1999 41
2000 43
2001 70
2002 101
2003 110
2004 247
2005 268
2006 276
2007 342
2008 345
2009 307
2010 337
2011 287
2012 224
2013 275
2014 324
2015 306
2016 323
2017 373
2018 367
2019 326
2020 276
2021 300
2022 298
2023 192
2024 171

Search Results

7,237 results

Results by year

Filters applied: . Clear all
Page 1
Correction.
[No authors listed] [No authors listed] Curr Med Res Opin. 2023 Oct;39(10):I. doi: 10.1080/03007995.2023.2257985. Epub 2023 Oct 10. Curr Med Res Opin. 2023. PMID: 37729081 No abstract available.
Editorial.
[No authors listed] [No authors listed] Curr Med Res Opin. 2023;39(sup1):3-4. doi: 10.1080/03007995.2023.2190175. Curr Med Res Opin. 2023. PMID: 37088098 No abstract available.
Correction.
[No authors listed] [No authors listed] Curr Med Res Opin. 2022 Oct;38(10):1784. doi: 10.1080/03007995.2022.2107767. Epub 2022 Aug 9. Curr Med Res Opin. 2022. PMID: 35945892 No abstract available.
Correction.
[No authors listed] [No authors listed] Curr Med Res Opin. 2023 Sep;39(9):1287. doi: 10.1080/03007995.2023.2246730. Epub 2023 Aug 12. Curr Med Res Opin. 2023. PMID: 37571872 No abstract available.
Author's Response to Letter to the Editor - Re: Lin I, Melsheimer R, Bhak RH, et al. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin. 2022;38(4):613-627.
Young-Xu Y, Melsheimer R, Emond B, Lefebvre P, DerSarkissian M, Lax A, Nguyen C, Bhak RH, Wu M, Lin I. Young-Xu Y, et al. Curr Med Res Opin. 2022 Dec;38(12):2237-2240. doi: 10.1080/03007995.2022.2139970. Epub 2022 Nov 7. Curr Med Res Opin. 2022. PMID: 36274636 No abstract available.
Recommendations for preprints.
Sever R. Sever R. Curr Med Res Opin. 2022 Apr;38(4):607. doi: 10.1080/03007995.2022.2030597. Epub 2022 Feb 2. Curr Med Res Opin. 2022. PMID: 35040383 No abstract available.
7,237 results